Albany, NY -- (SBWIRE) -- 04/12/2016 -- Transparency Market Research presents a comprehensive analysis of the global bio-imaging technologies market in a report titled "Bio-imaging Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019." The report examines the market in a ground-up manner, presenting a detailed account of vital indicators such as drivers, challenges, and trends that will have an impact on the said market across North America, Asia Pacific, Europe, and Rest of the World in the 2013-2019 period.

Bio-imaging involves the utilization of tools and technologies to create physiological and anatomical images of living beings or living systems. In particular, medical imaging in bio-imaging refers to the utilization of tools and techniques to generate images of anatomical areas right from the molecular level to tissues to complete organ systems. This representation helps in disease diagnosis and investigation and also in creating a repository of data about normal physiology and anatomy for future use.

Today, medical imaging in an important element of clinical trial and enables rapid diagnosis with the help of visual and quantitative assessment. In addition, the technology is also indicative of the progression of a therapy. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are routine bio-imaging techniques for oncology and neuroscience studies.

Besides this, technological advancements, innovation of portable systems, potential utilization in the radiation oncology and cardiology sectors, increased utilization in non-hospital settings, and increasing demand for ultrasound imaging are factors that are collectively driving the bio-imaging technologies market. Increasing demand in women's health procedures, healthcare IT, and the bioinformatics industry will further boost the demand for bio-imaging technology modalities, adds the report.

Type of technology and geography are the two criteria based on which the global bio-imaging technologies market is segmented in this report. By technology, medical bio-imaging and molecular bio-imaging are the segments of this market. Molecular biology in bio-imaging involves spatial and temporal representation of biological macromolecules. Further breaking down, nano-bioimaging, optical, ultrasound imaging, radiological, magnetic resonance, and optical coherence tomography are the sub-segments of imaging technologies.

Currently, North America, followed by Europe, is the dominant regional market for bio-imaging technologies due to the considerable number of firms involved in developing and distributing bio-imaging solutions in this region. With further expansion of healthcare facilities in these regions expected in the coming years, the bio-imaging technologies market will receive a boost.

Request for Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2423

In Asia Pacific, China and India will emerge as significant markets for bio-imaging technologies in the coming years. The increasing number of technologically advanced hospitals equipped with modern digital solutions for diagnostics and treatment is the reason for the same.

The report mentions and profiles top players in the global bio-imaging market, namely BioClinica Inc., FONAR Corporation, Covidien Pharmaceuticals, Esaote S.p.A, Gamma Medica Inc., Positron Corporation, SonoSite Inc., Shimadzu Corporation, Bracco Imaging S.P.A, Bayer Healthcare Pharmaceuticals, Digirad Corporation, Hitachi Medical Corporation, GE Healthcare, Phillips Healthcare, Siemens Healthcare, and Toshiba Medical Systems Corporation.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/